KIT N822K
|
GIST
|
KIT N822K
|
GIST
|
dasatinib Sensitive: C3 – Early Trials
|
dasatinib Sensitive: C3 – Early Trials
|
KIT N822K
|
GIST
|
KIT N822K
|
GIST
|
imatinib Sensitive: C3 – Early Trials
|
imatinib Sensitive: C3 – Early Trials
|
KIT N822K
|
AML
|
KIT N822K
|
AML
|
imatinib Sensitive: D – Preclinical
|
imatinib Sensitive: D – Preclinical
|
KIT N822K
|
AML
|
KIT N822K
|
AML
|
GB-103 Resistant: D – Preclinical
|
GB-103 Resistant: D – Preclinical
|
KIT N822K
|
AML
|
KIT N822K
|
AML
|
sorafenib Resistant: D – Preclinical
|
sorafenib Resistant: D – Preclinical
|
KIT N822K
|
AML
|
KIT N822K
|
AML
|
ponatinib Sensitive: D – Preclinical
|
ponatinib Sensitive: D – Preclinical
|
KIT N822K
|
AML
|
KIT N822K
|
AML
|
dasatinib Sensitive: D – Preclinical
|
dasatinib Sensitive: D – Preclinical
|